letter · Drug Healthcare and Patient Safety

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]

Fawzi Thomas
Onome T. Abiri
Desmond Kangbai
Edna G Samuels
Joyce M Kallon
Thomas Conteh
Sally-Mattu Conteh
Olufunsho Awodele

2024Open accessUniversity of Lagos

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Vaccine Coverage and Hesitancy
SARS-CoV-2 and COVID-19 Research
Virology and Viral Diseases

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.2147/dhps.s496511

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.